Linorma T3 20mcg Tablet contains liothyronine sodium, a synthetic form of the thyroid hormone triiodothyronine (T3), at a dosage of 20 micrograms per tablet. It is primarily indicated for the treatment of hypothyroidism, including myxedema and other conditions associated with thyroid hormone deficiency, where rapid correction of thyroid hormone levels is necessary. Liothyronine acts by stimulating the basal metabolic rate, enhancing oxygen consumption, and increasing the metabolism of carbohydrates, fats, and proteins. This medication is also utilized in the management of certain types of goiter and as an adjunct in the diagnosis of thyroid disorders. Linorma T3 is absorbed rapidly from the gastrointestinal tract, with onset of action typically within hours, making it suitable for situations requiring prompt thyroid hormone replacement. Dosage must be individualized based on patient response, clinical condition, and laboratory parameters, with careful monitoring to avoid symptoms of hyperthyroidism such as tachycardia, nervousness, and weight loss. It is contraindicated in patients with untreated thyrotoxicosis and acute myocardial infarction. Caution is advised in patients with cardiovascular disease. Regular monitoring of thyroid function tests is essential to ensure therapeutic efficacy and safety during treatment with Linorma T3 20mcg Tablet.